• NMOSD Part 3 - Overview of treatment, including goals, triggers, and considerations for switching therapies

  • Feb 29 2024
  • Length: 20 mins
  • Podcast

NMOSD Part 3 - Overview of treatment, including goals, triggers, and considerations for switching therapies  By  cover art

NMOSD Part 3 - Overview of treatment, including goals, triggers, and considerations for switching therapies

  • Summary

  • In this series, Derrick Robertson, MD, Director of the Multiple Sclerosis Division at the University of Southern Florida discusses multiple aspects of NMOSD. Dr. Robertson is talking with us today on behalf of Horizon Therapeutics which is compensating him for his services and is sponsoring this podcast. In this episode, Dr. Robertson presents an overview of NMOSD treatment, including goals, triggers, and considerations for switching therapies. DA-UNBR-US-02296-2 05/2024 Sponsored by Horizon Therapeutics
    Show more Show less
activate_primeday_promo_in_buybox_DT

What listeners say about NMOSD Part 3 - Overview of treatment, including goals, triggers, and considerations for switching therapies

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.